Tauriga Sciences, Inc.’s Board of Directors Unanimously Votes to Terminate Its Equity Line of Credit Due to Substantially Improved Fundamentals, Macro-Business Outlook, and Balance Sheet
January 07, 2021 08:00 ET | Tauriga Sciences
NEW YORK, NY, Jan. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a...
Tauriga Sciences Inc. Enters Into $5,000,000 Equity Line of Credit Facility to be Registered on Form S-1
January 23, 2020 07:38 ET | Tauriga Sciences
Financing Agreement Supports the Company’s Ongoing Efforts to Develop Pharmaceutical Anti-Nausea Product NEW YORK, NY, Jan. 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences,...
BTCS Announces Letter to Shareholders from CEO
July 29, 2019 08:33 ET | BTCS Inc.
Balance Sheet Strengthened with $1.24m Raised in 2019 Silver Spring, MD, July 29, 2019 (GLOBE NEWSWIRE) -- BTCS Inc. (OTCQB: BTCS) (“BTCS” or the “Company”), a digital asset and blockchain...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC
April 22, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...